Black Diamond Therapeutics, Inc. (BDTX)
Nasdaq: BDTX · Biological Products, (No Diagnostic Substances) · Cambridge, MA · filing with the SEC since 2017
The company now
Black Diamond Therapeutics, Inc. is classed by the SEC under Biological Products, (No Diagnostic Substances) (industry code 2836), based in Cambridge, MA. In its latest annual figures on file, for the fiscal year ended 2025-12-31, it reported revenue of $70 million and a profit of $22 million (its filed statements).
From its filings and filed figures; the desk's account of it is not written yet.
The desk's written account, its read of the annual report, the record in brief and the split of the revenue are not on file for this company yet.